← Back to Analyst Consensus 
EVH Buy
Evolent Health, Inc.
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 18, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 17, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 12, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Aug 11, 2026 | Citigroup | upgrade | Neutral → Buy | — | 54% |
| Aug 10, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 28, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 23, 2026 | Citigroup | downgrade | Buy → Neutral | — | 54% |
| Jul 21, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 30, 2026 | Truist Securities | downgrade | Buy → Hold | — | 54% |
| Jun 12, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| May 15, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 12, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 7, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 2, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Feb 26, 2026 | Citigroup | maintain | Buy → Buy | $4 | 54% |
| Feb 26, 2026 | UBS | maintain | Buy → Buy | $5 | 54% |
| Feb 26, 2026 | Truist Securities | maintain | Buy → Buy | $6 | 54% |
| Feb 25, 2026 | Needham | maintain | Buy → Buy | $4 | 50% |
| Feb 25, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | $3 | 55% |
| Feb 25, 2026 | Keybanc | downgrade | Overweight → Sector Weight | $0 | 53% |
| Feb 25, 2026 | BTIG | maintain | Buy → Buy | $8 | 52% |
| Feb 2, 2026 | BTIG | maintain | Buy → Buy | $10 | 52% |
| Jan 9, 2026 | Citigroup | maintain | Buy → Buy | $6 | 54% |
| Jan 6, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $10 | 47% |
| Nov 21, 2025 | Citigroup | maintain | Buy → Buy | $9.5 | 54% |
| Nov 17, 2025 | JP Morgan | maintain | Overweight → Overweight | $7 | 54% |
| Nov 14, 2025 | Canaccord Genuity | maintain | Buy → Buy | $9 | 48% |
| Nov 13, 2025 | BMO Capital | initiate | — → Outperform | $7 | 53% |
| Nov 12, 2025 | Oppenheimer | maintain | Outperform → Outperform | $12 | 52% |
| Nov 10, 2025 | Truist Securities | maintain | Buy → Buy | $10 | 54% |
| Nov 10, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $11 | 47% |
| Nov 7, 2025 | BTIG | maintain | Buy → Buy | $16 | 52% |
| Sep 30, 2025 | BTIG | reiterate | Buy → Buy | $20 | 52% |
| Sep 24, 2025 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $9 | 54% |
| Sep 9, 2025 | Canaccord Genuity | maintain | Buy → Buy | $16 | 48% |
| Sep 9, 2025 | BTIG | reiterate | Buy → Buy | $20 | 52% |
| Aug 28, 2025 | Piper Sandler | maintain | Overweight → Overweight | $18 | 54% |
| Jul 17, 2025 | Truist Securities | maintain | Buy → Buy | $16 | 54% |
| Jun 20, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $13 | 53% |
| May 13, 2025 | Needham | reiterate | Buy → Buy | $15 | 50% |
| May 9, 2025 | UBS | maintain | Buy → Buy | $15 | 54% |
| Apr 28, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $13 | 53% |
| Apr 10, 2025 | Truist Securities | maintain | Buy → Buy | $14 | 54% |
| Mar 10, 2025 | JP Morgan | maintain | Overweight → Overweight | $12 | 54% |
| Feb 24, 2025 | Citizens Capital Markets | maintain | Market Outperform → Market Outperform | $13 | 49% |
| Feb 21, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $16 | 54% |
| Feb 21, 2025 | Needham | reiterate | Buy → Buy | $15 | 50% |
| Feb 14, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $12 | 53% |
| Feb 12, 2025 | Needham | reiterate | Buy → Buy | $15 | 50% |
| Jan 28, 2025 | JP Morgan | maintain | Overweight → Overweight | $13 | 54% |
Price Target Trend
Apr 24, 2026 Latest: $5.75 Oct 24, 2026
EPS Estimates
0q $0.06
Lo: $0.01 Hi: $0.09
9 analysts ▲1
+1q $0.15
Lo: $0.12 Hi: $0.19
8 analysts +1y $0.40
Lo: $0.28 Hi: $0.52
9 analysts ▲1
0y $0.20
Lo: $0.10 Hi: $0.27
9 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days